Penetration of pefloxacin into maxillary sinus cavity and nasal secretions.
The ability of oral pefloxacin to penetrate into maxillary sinus cavity and nasal secretions was studied in 39 patients suffering from an exacerbation of chronic maxillary sinusitis. The mean levels of pefloxacin in sinus aspirate fluid 0, 3, 6, 9 and 12 h after the second oral dose of 400 mg were 2.30, 6.92, 3.74, 3.47 and 2.82 mg/l respectively. In sinus cystic fluid (macroscopically non-purulent) the mean pefloxacin levels were 2.30, 7.15, 4.20 and 4.15 mg/l respectively, and in nasal secretion 1.90, 9.05, 3.71, 3.20 and 2.85 mg/l respectively. The mean pefloxacin levels in serum obtained simultaneously were 1.50, 5.00, 3.10, 2.70 and 2.20 mg/l respectively. It is concluded that pefloxacin accumulates in inflamed sinus fluid at concentrations exceeding blood levels.
Petrikkos
G
G
Department of Propedeutic Medicine, Athens University School of Medicine, Laiko General Hospital, Greece.
Goumas
P
P
Moschovakis
E
E
Giamarellou
H
H
D000328:Adult; D002908:Chronic Disease; D005260:Female; D006193:Haemophilus influenzae / Q000302:isolation & purification; D006801:Humans; D008297:Male; D008443:Maxillary Sinus / Q000378:metabolism* / Q000382:microbiology; D015523:Maxillary Sinusitis / Q000188:drug therapy; D008875:Middle Aged; D009297:Nasal Mucosa / Q000378:metabolism* / Q000382:microbiology; D015366:Pefloxacin / Q000032:analysis / Q000493:pharmacokinetics* / Q000627:therapeutic use; D013210:Staphylococcus / Q000302:isolation & purification; D013291:Streptococcus / Q000302:isolation & purification
D015366:Pefloxacin